K-V Pharma Judge Greenlights Reorganization Plan

Law360, New York (August 28, 2013, 2:42 PM EDT) -- K-V Pharmaceutical Co. on Wednesday received a bankruptcy judge’s approval of its reorganization plan that will allow it to exit the Chapter 11 process and continue its business following a competitive bidding process.

U.S. Bankruptcy Judge Allan L. Gropper commended K-V and its counsel for producing a workable plan within a year of its tumble into bankruptcy. The health care company sought Chapter 11 protection after it was unable to make a $45 million payment due to Hologic Inc. under a rights agreement related to its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.